// App-Quantinova.ai

: Anti‐factor Xa Levels Correlate with Recurrent Venous Thromboembolism and Clinically Relevant Bleeding in Patients Receiving Low‐molecular‐Weight Heparin

Researchers

Presenter

  • L. Valerio

Principal Investigators

  • S.M. Romero

  • M.I. Asensio Cruz

  • T.E. Hernandez

  • O. Candelera

  • S. Barco

  • L.J. Palomares

Medical Centers

  • University Medical Center of the Johannes Gutenberg University, Center for Thrombosis and Hemostasis (CTH), Mainz, Germany

  • Instituto de Biomedicina de Sevilla (IBiS), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Medical Surgical Unit of Respiratory Diseases, Sevilla, Spain

Locations

  • Germany

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A